AUS
NZ
UK
CA
USA
IND
.jpg)
On July 23, 2026, Bed Bath & Beyond, Inc. revealed it has signed a definitive merger agreement to acquire F9 Brands, Inc., a portfolio company under F9 Investments, LLC. The acquisition will be executed through Bed Bath & Beyond's wholly owned subsidiary, Beyond Home Services, LLC, pending customary closing conditions. This deal incorporates cash, equity, real estate transfers, and contingent earnout payments, marking a substantial enhancement to Bed Bath & Beyond's product range and operational capacity.
Key Points
- Stock symbols: NYSE: BBBY and NYSE: BBBY-WT (common stock and warrants of Bed Bath & Beyond)
- Merger agreement with F9 Brands executed on July 23, 2026
- Merger consideration includes $7 million cash, approximately 18.1 million Bed Bath & Beyond common shares, two manufacturing plants in Sweden, one in Poland, a $4.6 million promissory note due within 90 days post-closing, and up to $12.5 million in contingent earnout payments
- Earnout contingent on F9 Brands subsidiaries achieving a minimum of $20 million trailing twelve-month EBITDA from the quarter ending September 30, 2026 through December 31, 2031
Merger Structure and Corporate Framework
The transaction will proceed via a two-step merger designed to integrate F9 Brands into Bed Bath & Beyond’s operating subsidiary. Beyond Home Services, LLC, a wholly owned subsidiary of Bed Bath & Beyond, will oversee two merger entities: F9 Merger Sub 1, Inc. (a Delaware corporation) and F9 Merger Sub 2, LLC (a Delaware limited liability company). Initially, F9 Merger Sub 1 will merge into F9 Brands, Inc., followed immediately by F9 Brands merging into F9 Merger Sub 2, which will remain as a wholly owned subsidiary of Beyond Home Services, LLC, thus becoming part of Bed Bath & Beyond’s corporate structure.
The transaction involves multiple parties, including the Seller, F9 Investments, LLC (a Florida limited liability company), and Tom Sullivan, the indirect owner of the Seller. Sullivan has agreed to participate in specific provisions of the Merger Agreement concerning representations, warranties, and post-closing covenants. This multi-party arrangement reflects the complexity of integrating F9 Brands’ manufacturing operations across international jurisdictions into Bed Bath & Beyond’s existing platform.
Detailed Merger Consideration Components
The total merger consideration consists of five elements balancing immediate cash, equity participation, real estate, and contingent payments. The Seller will receive $7 million in cash at closing (Cash Purchase Price). Bed Bath & Beyond will also issue approximately 18.1 million common shares, adjusted for employee incentive program payments divided by a conversion factor of 6.95 (Equity Purchase Price), aligning the Seller’s stake with Bed Bath & Beyond’s stock performance post-closing.
Additionally, the Seller will acquire real estate assets consisting of two manufacturing facilities in Sweden and one in Poland, representing significant operational infrastructure. A $4.6 million promissory note, guaranteed by Bed Bath & Beyond and payable within 90 days of closing, constitutes the fourth component. Lastly, contingent earnout payments up to $12.5 million will be made if F9 Brands’ subsidiaries meet specified financial milestones during the earnout period.
Earnout Conditions and Timeline
The earnout, capped at $12.5 million, is performance-based and contingent on F9 Brands’ subsidiaries achieving at least $20 million in trailing twelve-month EBITDA at the end of any fiscal quarter starting with Q3 2026 through Q4 2031. This approximately five-and-a-half-year earnout period aligns Seller incentives with the long-term success of the acquired business under Bed Bath & Beyond’s management.
Earnout payments will be distributed to the Seller and, unless otherwise directed, allocated to certain Target employees who remain employed by Bed Bath & Beyond and affiliates through the payment dates, fostering employee retention and aligning workforce performance with earnout realization.
Closing Conditions and Regulatory Compliance
Completion is contingent upon customary closing conditions protecting both parties. These include the absence of legal impediments, no pending or threatened proceedings materially affecting closing, and no Material Adverse Effect since July 23, 2026. Delivery of required financial documents—2025 audited statements, Q1 2026 unaudited statements, and if closing extends beyond August 12, 2026, additional unaudited statements for periods ending June 30, 2026—is mandatory. All representations and warranties must be materially accurate, and parties must comply materially with their obligations under the agreement.
Representations, Warranties, and Pre-Closing Obligations
Both Seller and Bed Bath & Beyond provide customary representations and warranties addressing standard acquisition topics to allocate risk. The Seller has agreed to conduct covenants, including non-solicitation and non-initiation of alternative proposals pre-closing, and post-closing non-competition and non-solicitation restrictions. Post-closing, both parties will adhere to limitations on the use of F9 Brands’ intellectual property to preserve proprietary assets for Bed Bath & Beyond’s operations.
Termination Rights and Cure Provisions
Mutual termination rights allow either party to terminate the agreement on or after October 31, 2026, approximately three months after signing, except where a party’s failure to fulfill obligations caused the closing failure. Termination is also possible by mutual consent or material breach of representations, warranties, or covenants, subject to cure periods. These provisions provide orderly exit mechanisms if closing conditions are unmet.
International Manufacturing Facilities and Real Estate Transfer
The transfer of two manufacturing facilities in Sweden and one in Poland as part of the merger consideration highlights the operational significance beyond cash and equity. These assets indicate F9 Brands’ manufacturing footprint across Nordic and Central Europe, potentially reflecting vertically integrated operations or established supply chains. Bed Bath & Beyond’s transfer of these properties suggests a strategic realignment of its real estate portfolio to consolidate F9 Brands’ business and intellectual property within its structure.
Details on the operational capacity or role of these facilities remain undisclosed, leaving further insights to future public disclosures.
Transaction Timing and Market Context
Announced and executed on July 23, 2026, the merger anticipates a near-term closing, with financial documentation deadlines set for August 12, 2026. The October 31, 2026 termination right allows additional time if regulatory or operational challenges arise. This acquisition underscores Bed Bath & Beyond’s strategic expansion in its product categories and operational capabilities.
Investors are advised to review the full Merger Agreement filed as Exhibit 2.1 to the Current Report for comprehensive transaction details. The agreement’s representations and warranties may be subject to negotiated limitations and confidential disclosures, with materiality standards differing from typical investor assessments.
Investor Caution on Representations and Warranties
The filing emphasizes that the Merger Agreement’s representations, warranties, covenants, and agreements serve to allocate risk among parties and are not factual statements for investor reliance. These may not reflect the actual state of affairs at signing or thereafter. Investors should not rely on these disclosures as factual representations about Bed Bath & Beyond, F9 Brands, or related parties.
Modifications or qualifications based on confidential disclosures and differing materiality standards may apply. Investors seeking complete information should consult the full Merger Agreement and monitor future disclosures from Bed Bath & Beyond regarding the transaction’s progress and material developments.
